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Human cytomegalovirus escapes 
immune recognition by NK cells 
through the downregulation of 
B7-H6 by the viral genes US18 and 
US20
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Cavaletto4, Rachel Yamin1,6, Dominik Schmiedel1, Dana Wolf3, Giorgio Gribaudo4, Martin 
Messerle  5, Luka Cicin-Sain  2,5 & Ofer Mandelboim1
Human cytomegalovirus (HCMV) is a major human pathogen, causing serious diseases in 
immunocompromised populations and congenially infected neonates. One of the main immune cells 
acting against the virus are Natural Killer (NK) cells. Killing by NK cells is mediated by a small family of 
activating receptors such as NKp30 that interact with the cellular ligand B7-H6. The outcome of B7-H6-
NKp30 interaction was, so far, mainly studied with regard to NK recognition and killing of tumors. Here, 
we demonstrated that the expression of B7-H6 is upregulated following HCMV infection and that HCMV 
uses two of its genes: US18 and US20, to interfere with B7-H6 surface expression, in a mechanism 
involving endosomal degradation, in order to evade NK cell recognition.
HCMV, also known as Human Herpesvirus 5 (HHV-5), is an important human pathogen, a member of the 
Betaherpesvirus family. It infects the majority of the human population, and following primary infection, it can 
persists as a life-long infection1. While healthy individuals experience the infection as mild or sub-clinical, HCMV 
poses a major threat to immune-compromised populations such as transplant recipients or AIDS patients, and is 
a significant cause of infection-related congenital defects and abortions2, 3. The virus contains a dsDNA genome, 
the largest of the herpesvirus family, which codes for hundreds of genes. Out of these, many are used to evade 
immune recognition4–7, with an emphasis on escape from the innate immune attack8, 9.
NK cells that belong to the innate immunity system play a critical role in fighting HCMV infections. Indeed, 
individuals that suffer from NK cell deficiency suffer from a higher susceptibility to different herpesvirus infec-
tions, including HCMV10. NK cells have recently also been classified as a cytotoxic type of Innate Lymphoid 
Cells (ILCs)11. They constitute 5–15% of the lymphocytes in healthy peripheral blood, and are capable of killing 
virally-infected cells, tumor cells12, bacteria13, 14 and fungi15. NK cells function through the secretion of inflamma-
tory cytokines such as IFNγ, and through direct lysis of cells12. The decision of whether or not to kill an inspected 
cell is mediated by a balance of signals generated by inhibitory and activating receptors. Inhibitory receptors 
mainly recognize self-molecules such as MHC class I and PVR12, 16 Activating receptors recognize several ligands 
which can be either self or non-self (pathogen-derived) and are upregulated following cellular stress, cancerous 
process or infection17. NKG2D is an NK killer receptor that recognizes 8 human stress induced ligands: MICA, 
MICB and ULBP 1–618. MICA has dozens of different alleles19 that include long cytoplasmic tail proteins and 
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short tail proteins such as MICA *008 that is GPI-linked to the membrane20. The expression of NKG2D lig-
ands, including the long and short alleles of MICA, is prevented during HCMV infection by both protein and 
microRNA-based mechanisms8.
NKp30 is a major NK activating receptor. Known ligands of NKp30 include the Plasmodium falciparum pro-
tein PfEMP-121, the cellular nuclear factor BAT322, 23, and the cellular membrane protein B7-H624, while recogni-
tion of the HCMV protein pp65 is inhibitory to NKp30-mediated killing25.
B7-H6 contains two Ig-like domains, and its structure bound to NKp30 has been solved26. While it is not 
found to be expressed on healthy cells, it has been shown to be upregulated on the surface of both solid and 
hematologic transformed cells24. The exact mechanisms controlling B7-H6 expression are still largely unknown, 
but it was demonstrated that several TLR ligands and pro-inflammatory cytokines can induce its expression in 
non-transformed cells27.
The role played by B7-H6 in tumor surveillance has been quite extensively studied. However, its function in 
anti-viral immunity remains poorly explored. Only recently, B7-H6 was shown to be involved in viral infection, as 
it was demonstrated that B7-H6 is downregulated during infection with another member of the Betaherpesvirus 
family, HHV-628. The viral protein responsible for this downregulation is unknown.
Here we show that HCMV, via US18 and US20, downregulates B7-H6 surface expression during infection to 
escape NK cell attack.
Results
The HCMV US14-22 genomic region encodes several immune evasion mechanisms. The 
HCMV genome contains many immune evasion genes, several of which are designed to prevent NK cell recogni-
tion of infected cells. One gene family coding for such proteins is the US12 gene family that includes a set of ten 
contiguous tandemly arranged genes (US12 to US21) in the unique short (US) region of the HCMV genome4–7. 
Among the US12 genes, US18 and US20 were previously shown to downregulate the NKG2D ligand MICA29.
In order to identify additional NK evasion mechanisms mediated by the US12 gene family, we infected pri-
mary Human Foreskin Fibroblast (HFF) cells with two strains of HCMV: a wild type TB40/e virus and a TB40/e 
mutant virus deleted for the US14-22 genomic region (ΔUS14-22). 96 hours following infection, the cells were 
stained for expression of various NK ligands. As previously described30 both HCMV strains reduced surface 
expression of HLA-I, β2-microglobulin (β2 m), MICB and ULBP2, the last two being ligands for the activating 
receptor NKG2D18 (Fig. 1A). No significant change in ULBP1 or PVR surface expression was detected and a slight 
increase in ULBP3 levels during infection with both strains was noticed (Fig. 1A).
An increase in MICA surface expression was observed after infection with HCMV ΔUS14-22, while infection 
with the WT strain led to a complete repression of MICA surface expression (Fig. 1A). This is because the HFF 
line used here (FLS1) express two full-length MICA alleles that are targeted by US18 and US20 that are present in 
the US12 region29, 31. Interestingly, an increase in B7-H6 surface expression levels was detected, but only during 
infection with the HCMV strain lacking the US14-22 genomic region (Fig. 1A). To further corroborate these 
findings we infected the human retinal pigment epithelium cell line ARPE19, and observed a very pronounced 
upregulation of B7-H6 in the US14-22-deleted virus (Fig. 1B). Since B7-H6 is already expressed on the surface 
of ARPE19 cells (as opposed to the HFF negative cells, Fig. 1A), we also observed that the WT TB40/e strain was 
able to downregulate the endogenous B7-H6 expression (Fig. 1B).
HCMV US18 and US20 are responsible for the B7-H6 downregulation. Next, we wanted to deter-
mine whether one or more of the canonical genes encoded within the US14-22 genomic region is responsible for 
B7-H6 downregulation. We deleted overlapping groups of genes within this region: US14-16, US16-18, US17-20 
and US19-22 (schematically described in Fig. 2A), by replacing them with a kanamycin resistance gene. ARPE19 
cells were infected with these mutant viruses and B7-H6 expression was determined using flow cytometry. While 
HCMV deleted for US14-16 retained the same phenotype as the WT virus, deletion of either US16-18, US17-20 
or US19-22 resulted in loss of ability to downregulate B7-H6 (Fig. 2B, quantified in Fig. 2C). The fact that deletion 
of two non-overlapping regions (US16-18 and US19-22) interfered with the virus’ ability to prevent B7-H6 sur-
face expression indicates the existence of at least two non-redundant genetic elements within these two genomic 
regions that are required for the observed effect. Because similar observations were made with ΔUS17-20 which 
partially overlaps both suspected regions, we hypothesized that the two genes might be US18 and US20.
To identify the specific genes involved, we generated single deletions in the US17-20 region. The expression of 
HCMV genes US18, US19 and US20 is dictated by a complex regulatory mechanism that is not yet fully under-
stood. Under different conditions and at different infection time points US18, US19 and US20 can be transcribed 
as a tri-cistronic mRNA containing all three ORFs32. However, US18 can also be transcribed as an independent 
transcript, and it is possible that a US19-20 transcript also exists32. To avoid the possibility that complete deletion 
of one of these ORFs will lead to interference with the transcription of other genes included in this poly-cistronic 
mRNA, we chose to interfere with the expression of the suspected genes only at the level of translation, by replac-
ing the start codon of each of them with a stop codon (ATG→TAA). Thus, we generated four silent deletion 
strains: US17stop, US18stop, US19stop and US20stop. ARPE19 cells were infected with these strains and B7-H6 
surface expression levels were again examined using FACS. Only HCMV US18stop was unable to inhibit B7-H6 
surface expression (Fig. 2D quantified in Fig. 2E).
This result was surprising because we inferred from our block deletion mutants that both US18 and US20 
might be involved in the B7-H6 downregulation. Furthermore, HCMV US18 and US20 were previously shown 
to act together in the downregulation of MICA29. We therefore wondered whether indeed US20 is not involved 
in the B7-H6 downregulation.
US20 contains a second ATG start codon, in frame, 39 nucleotides downstream of the first start codon that 
we have replaced. We therefore speculated that it is possible that the virus is able to translate a truncated but still 
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functional US20 protein using this start codon, in our US20stop HCMV mutants. Alternatively, it is possible 
that US20 is transcribed from a non-canonical start codon that were previously shown to be prevalent in the 
HCMV genome6. Thus, to test whether indeed US20 is not involved in the B7-H6 downregulation, we infected 
ARPE19 cells with HCMV TRΔUS20 strain, a derivative of the clinical isolate strain TR, in which the entire 
US20 ORF was replaced with a galK-Kan cassette33. As a control, we used the TRUS20HA revertant virus, in 
which a HA-tagged US20 ORF was reconstituted into the deleted region of TRΔUS2033. We observed that cells 
infected with HCMV TRΔUS20 expressed two-fold higher levels of surface B7-H6, which was not observed with 
the revertant virus (Fig. 2F, quantified in Fig. 2G). Consequently, we concluded that the HCMV genes US18 and 
US20 act in a non-redundant fashion to downregulate the expression of the NK activating ligand B7-H6 from the 
surface of infected cells.
Exogenous overexpression of US18 and US20 is sufficient for reducing B7-H6 surface expres-
sion. Our previous set of experiments using HCMV deletion mutants has demonstrated that US18 and US20 
are non-redundant in their capacity to downregulate B7-H6. To determine whether they are sufficient or whether 
they work in concert with additional HCMV genes, we overexpressed 6XHis-tagged US17, US18, US19 or US20 
in ARPE19 cells by using lentivirus-based vectors. No difference in B7-H6 surface expression was observed 
between cells overexpressing the different proteins and cells carrying the empty vector alone (Fig. 3A). We next 
Figure 1. The HCMV US14-22 genomic region encodes several immune evasion mechanisms. (A) FACS 
staining for different NK cell ligands on Human Foreskin Fibroblast cells, 96 hours after infection with WT 
HCMV TB40/e or HCMV TB40/e deleted for the US14-22 genomic region (or control uninfected cells, as 
depicted in the figure legend). Filled gray histograms represent staining with the relevant isotype control 
antibodies. A representative isotype control staining derived from the uninfected cells is presented as no 
significant differences were observed between isotype control stainings for each infection. (B) FACS staining 
of B7-H6 surface expression on ARPE19 cells infected with different HCMV strains as depicted in the figure 
legend. No significant differences were observed between isotype control stainings of each infection, so a 
representative isotype control staining derived from the uninfected cells is presented.
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Figure 2. HCMV US18 and US20 are responsible for the B7-H6 downregulation phenotype. (A) Schematic 
representation of HCMV US14-US22 genomic region and the different block deletion mutants used in this 
study. Blue arrows represent US12-family genes. Red arrows represent US22-family genes. Double headed 
arrows represent genomic regions deleted in the different block-deletion mutants. (B) FACS staining of B7-H6 
surface expression on ARPE19 cells infected with different HCMV TB40/e strains deleted for gene blocks 
within the US14-22 genomic region. Histogram colors are as depicted in the figure legend. One representative 
experiment out of seven is presented. No significant differences were observed between isotype control stainings 
of each infection, so a representative isotype control staining derived from the uninfected cells is presented. (C) 
Quantification of the results presented in B. Averages of seven experiments are presented. Error bars represent 
standard error of the mean. (D) FACS staining of B7-H6 surface expression on ARPE19 cells infected with 
different HCMV TB40/e strains in which the start codon of one ORF out of the US17-20 region was replaced 
with a stop codon. Histogram colors are as depicted in the figure legend. One representative experiment out of 
three is presented. No significant differences were observed between isotype control stainings of each infection, 
so a representative isotype control staining derived from the uninfected cells is presented. (E) Quantification of 
the results presented in D. Averages of three experiments are presented. Error bars represent standard error of 
the mean. (F) FACS staining of B7-H6 surface expression on ARPE19 cells infected with different HCMV TR 
derivatives. Histogram colors are as depicted in the figure legend. One representative experiment out of four 
is presented. No significant differences were observed between isotype control stainings of each infection, so 
a representative isotype control staining derived from the uninfected cells is presented. (G) Quantification of 
the results presented in F. Averages of four experiments are presented. Error bars represent standard error of 
the mean. ANOVA tests were performed in order to evaluate significance. *p-value < 0.05. **p-value < 0.005. 
***p-value < 0.0005. N.S. = non-significant differences.
Figure 3. Exogenous overexpression of US18 and US20 is sufficient for reducing B7-H6 surface expression. 
(A) FACS staining for B7-H6 on ARPE19 cells overexpressing HCMV US17, US18, US19 or US20, as presented 
above the relevant graphs. Histogram colors are as depicted in the figure legend. One representative experiment 
out of ten is presented. (B) Quantification of the results presented in A. Averages of four to ten experiments are 
presented. Error bars in B represent standard error of the mean. An ANOVA test was performed in order to 
evaluate significance. *p-value < 0.05. N.S. = non-significant differences.
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performed another round of lentivirus transduction, this time overexpressing HA-tagged US20 on the back-
ground of US18-His, and identified a significant (p = 0.0077) reduction in B7-H6 levels (Fig. 3A, quantified in 
Fig. 3B). Thus, only US18 and US20 together are sufficient for B7-H6 downregulation.
B7-H6 is sent to degradation during HCMV infection. To identify the molecular mechanism by which 
US18 and US20 inhibit B7-H6 surface expression we initially determined the B7-H6 mRNA levels. We extracted 
mRNA from uninfected ARPE19 cells, and ARPE19 cells infected with either the mutant US18stop that is una-
ble to reduce B7-H6 surface expression, or with the US19stop mutant which retains the ability to downregulate 
B7-H6 and observed no change in mRNA levels of B7-H6 (Fig. 4A). Infection levels of US18stop and US19stop 
were similar as determined by qRT-PCR experiments using the HCMV gene US9 (Fig. 4B).
Next, we tested whether the decrease in B7-H6 surface expression is due to a general decrease in cellular B7-H6 
protein quantity, as has been shown for the downregulation of MICA by US18 and US2029. Since the expression of 
B7-H6 in ARPE19 cells is low, we stably overexpressed B7-H6 fused to a C-terminal FLAG-tag in these cells. FACS 
experiments were then performed in order to validate the increased B7-H6 expression and the ability of HCMV 
US18stop and US19stop to replicate the effects observed for endogenous B7-H6 (Sup. Fig. S1). We then infected 
the cells with HCMV US18Stop or US19Stop, and 72 hours post-infection prepared protein lysates. Western blot 
experiments were performed using antibodies against the FLAG-tag (as the commercial anti-B7-H6 mAb does 
not work in western blot assays), while Vinculin levels were used as a loading control. Interestingly, a strong 
decrease in B7-H6 protein levels was observed during infection with US19stop, (Fig. 4C, quantified in 4D), while 
infection with US18Stop had no effect, suggesting that during infection B7-H6 is being degraded.
Lysosomal degradation is involved in the HCMV-induced B7-H6 downregulation. To further study 
the mechanism by which HCMV degrades B7-H6 we repeated the western blot experiment depicted in Fig. 4C 
in the presence of two proteasome inhibitors – Epoxomycin (Epox) and Bortezomib (BTZ), and two lysosome 
inhibitors – Concanamycin A (CCMA) and Leupeptin (Leu). While proteasome inhibition didn’t rescue B7-H6 
levels during infection, an increase in the protein levels was detected when lysosomal inhibitors were used (Fig. 4E).
To further corroborate these data ARPE19 cells stably overexpressing FLAG-tagged B7-H6 were infected 
for 72 hours with the GFP-expressing HCMV mutant US19Stop or left uninfected, in the presence or absence 
of the lysosome inhibitor CCMA. The cells were stained for the FLAG-tag (indicative of B7-H6 expres-
sion), the nucleus (using DAPI), and for either the lysosomal marker CD107A (Fig. 5A) or the ER marker 
Protein-Disulfide-Isomerase (PDI) (Fig. 5B). A significant negative correlation was observed between infection 
levels (determined by GFP) and cellular B7-H6-FLAG levels (Pearson’s coefficient of R = −0.54), indicating that 
B7-H6 is degraded.
As expected, B7-H6-FLAG was expressed mainly on the cell surface of uninfected cells while in 
HCMV-infected cells we observed substantially reduced levels of B7-H6-FLAG (Fig. 5A–C, marked by yellow 
lines). In infected cells treated with the lysosomal inhibitor CCMA, more B7-H6-FLAG was observed and the 
degree of B7-H6-FLAG degradation was less pronounced (Fig. 5A–C). In addition, under lysosomal inhibition 
we observed an intracellular, peri-nuclear accumulation of B7-H6-FLAG (Fig. 5A and B, marked by an arrow). 
This population was seen following infection and increased following the addition of CCMA. We also observed 
that following HCMV infection, CD107A (a lysosomal marker) was co-localized to the peri-nuclear compart-
ment, together with B7-H6-FLAG, when the lysosome is inhibited (Fig. 5A, CCMA). As previously shown, this 
peri-nuclear CD107A-positive compartment is most likely the Viral Assembly Compartment34, 35. The ER staining 
(detected by PDI) was not changed during infection and was not co-localized with B7-H6-FLAG (Fig. 5B).
Overall we suggest that during HCMV infection B7-H6 is localized to the Viral Assembly Compartment and 
later degraded, at least partially, by the lysosomes.
HCMV downregulation of B7-H6 leads to evasion from NKp30-medited killing by NK cells. Finally, 
we studied the functional significance of B7-H6 downregulation by US18 and US20 with regard to evasion from NK 
cells. We incubated 35S-Methionine-labeled ARPE19 cells that were left uninfected or infected with HCMV US18stop 
or with US19stop with primary NK cells and performed NK cytotoxicity assays. Infection with HCMV US19stop led 
to evasion from NK cell mediated killing, as the infected cells were hardly killed (Fig. 6A).We think that the reduced 
killing of US19Stop-infected cells is because HCMV uses many mechanisms to evade recognition by NK cells8, 
including the US18 and US20-mediated downregulation of B7-H6 that we show here. In contrast, infection with 
the US18stop HCMV mutant led to the opposite effect, and considerably increased killing of the infected cells was 
observed (Fig. 6A). This is probably because of the upregulation in B7-H6 expression observed following HCMV 
infection in the absence of US18 (see above figures).
To determine the involvement of NKp30, NKG2D or both receptors we repeated the NK killing experiments, 
this time incubating the NK cells with specific antibodies that block NKp30 and NKG2D interactions. In unin-
fected cells, a slight reduction in killing was observed following blocking with anti-NKp30, anti-NKG2D or both 
(Fig. 6B). This reduction was not observed in cells infected with the US19stop virus, probably because of the 
reduction in the NKG2D and NKp30 ligands. A very pronounced increase in the killing of cells infected with 
HCMV US18stop was again observed (Fig. 6B), most likely due to the interference with the immune evasion 
effects of US18 and the increase in B7-H6. We observed a reduction in killing only following blocking of the 
NKp30 receptor, but not NKG2D (Fig. 6B). Blocking of both receptors resulted in a similar effect as blocking of 
NKp30 alone (Fig. 6B). Even in the presence of NKp30 inhibition, the reduction in NK killing did not reach the 
levels observed in uninfected cells or cells infected with US19stop (Fig. 6B), indicating the US18 and probably 
also US20 are involved in the downregulation of additional NK ligands that are recognized by other activating 
receptors.
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Figure 4. HCMV sends B7-H6 to degradation. (A) Quantitative RT-PCR for B7-H6 expression in ARPE19 
cells infected with HCMV US18stop, HCMV US19stop or left uninfected. Bar identities are as depicted in the 
figure. Relative B7-H6 mRNA quantity was normalized to the uninfected cells samples. The presented results 
are averages of 3 biological repeats. Error bars represent standard error of the mean. (B) Quantitative real-time 
PCR for US9 expression in ARPE19 cells infected with HCMV US18stop, HCMV US19stop or left uninfected. 
Bar identities are as depicted in the figure. Relative US9 mRNA quantity was normalized to the samples of cells 
infected with HCMV US19Stop. The presented results are averages of 3 biological repeats. Error bars represent 
standard error of the mean. (C) Western blot of HCMV infected ARPE19 cells overexpressing FLAG-tagged B7-
H6. The upper row presents a blot with an anti-FLAG antibody. The lower row presents a blot with anti-human 
Vinculin, used as a loading control. All samples derived from the same experiment were processed in parallel. 
One representative experiment out of three is presented. (D) Quantification of the results presented in C. 
Averages of three independent experiments are presented. Error bars represent standard deviation. (E) Western 
blot of HCMV infected ARPE19 cells overexpressing FLAG-tagged B7-H6 and treated with DMSO (10 μl/ml),  
Epoxomycin (Epox, 10 μM), Bortezomib (BTZ, 500 μM), Concanamycin A (CCMA, 50 nM), Leupeptin (Leu, 
500 μM) or left untreated (PBS). The upper row presents a blot with an anti-FLAG antibody. The lower row 
presents a blot with anti-human Vinculin, used as a loading control. The presented blots were cropped and 
the background was adjusted for clarity. A student’s t test was performed in order to evaluate significance. 
*p-value < 0.05. **p-value < 0.005. ***p-value < 0.0005. N.S. = non-significant differences.
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To further corroborate these results we repeated the NK cytotoxicity experiments in the presence of a B7-H6 
blocking antibody. While B7-H6 blockage did not significantly affect killing of HCMV U19Stop-infected cells 
(because B7-H6 was downregulated), it successfully decreased NK cytotoxicity against uninfected and HCMV 
US18Stop-infected cells (Fig. 6C).
Discussion
During the course of evolution and the arms race between HCMV and its human host, the virus has developed a 
large array of immune-evasion mechanisms, many of which are targeted against NK cell recognition of HCMV 
infected cells.
Here we demonstrate that B7-H6 surface expression is upregulated during HCMV infection, and identify the 
viral genes that counter this effect. Using a series of HCMV mutants, we determine that the US12-family genes 
US18 and US20 are necessary for the downregulation of B7-H6 in two clinical strains of HCMV: TB40/e and 
TR. By overexpressing relevant US12-family member genes in uninfected cells, we show that both US18 and 
US20 are necessary and sufficient for the downregulation of B7-H6. While no significant change in the levels of 
B7-H6 mRNA was observed during infection, HCMV mutants lacking US18 were unable to downregulate B7-H6 
protein levels. This suggests that the mechanism/s HCMV uses to oppose B7-H6 mediated recognition work 
through the degradation of B7-H6, similarly to the action of US18 and US20 on the NK activating ligand MICA29. 
Although we cannot completely rule out the possibility that some of the observed decrease in B7-H6 results from 
shedding of the protein by infected cells, using a series of proteasome and lysosome inhibitors we observed that 
lysosomal degradation is involved in HCMV degradation of B7-H6 and that prior to its degradation B7-H6 is 
most likely located in the Viral Assembly Compartment. Finally, we showed that the US18- and US20-mediated 
downregulation of B7-H6 has a major effect on the ability of HCMV to evade elimination by NK cells.
US18 and US20 are now known to interfere with two NK ligands: MICA - a NKG2D ligand, and B7-H6 - a 
NKp30 ligand. Our killing data suggest that US18 and US20 probably interfere with the activity of additional NK 
cell ligands, making these two viral proteins prominent in manipulating NK cell activity.
We previously showed that HCMV directly interferes with NKp30 function through inhibitory binding of the 
viral protein pp65 to this receptor25, and we now show that HCMV also downregulates its ligand. The fact that 
HCMV manipulates multiple steps in the NKp30 pathway further demonstrates its importance for this particular 
virus.
Figure 5. Downregulation of B7-H6 during HCMV infection is mediated through lysosomal degradation. 
(A) ARPE19 cells overexpressing B7-H6-FLAG were infected with HCMV US19Stop or left uninfected, and 
were treated with 50 nM Concanamycin A (CCMA) or left untreated (DMSO). The cells were then stained with 
DAPI and antibodies against the FLAG-tag or the lysosomal marker CD107A, and visualized using confocal 
microscopy. GFP marks infected cells. Infected cells boundaries are marked by a yellow line. Yellow arrows mark 
intracellular accumulations of B7-H6-FLAG. (B) ARPE19 cells overexpressing B7-H6-FLAG were infected with 
HCMV US19Stop or left uninfected, and were treated with 50 nM Concanamycin A (CCMA) or left untreated 
(DMSO). The cells were then stained with DAPI and antibodies against the FLAG-tag or the ER marker PDI, 
and visualized using confocal microscopy. GFP marks infected cells. Infected cells boundaries are delineated 
using a yellow line. Yellow arrows mark intracellular accumulations of B7-H6-FLAG. (C) Quantification of the 
FLAG-tag fluorescence intensity shown in A. Averages of 45–85 cells from each category are presented, error 
bars represent standard error of the mean. A student’s t test was performed in order to evaluate significance. 
***p-value < 0.0005.
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Furthermore, we recently demonstrated that another herpesvirus, HHV-6, downregulates B7-H6 through 
an unknown mechanism28. Thus, we speculate that B7-H6 might have a role in the immune escape of additional 
viruses from other families as well, and that perhaps additional B7-H6 immune evasion mechanisms will also be 
discovered in HCMV.
The molecular mechanism responsible for B7-H6 induction and downregulation following virus and tumor 
transformation are still largely unknown. We don’t know what are the cellular signaling and transcription net-
works leading to the induction of B7-H6 during infection, and whether they differ from the signals used to 
upregulate B7-H6 during cancerous processes. Answers to these questions might allow us to develop methods to 
induce B7-H6 and NK-mediated killing during malignant and viral diseases, that otherwise evade such immune 
recognition and elimination.
While we were preparing this manuscript, another group has conducted a study regarding immune evasion 
mechanisms of HCMV US12 family genes. The study was performed on the Merlin HCMV strain, whereas in our 
study we used the TB40/e and TR strains. Importantly, both studies arrive at similar conclusions and thus they 
complement and strengthen each other, arguing that B7-H6 downregulation by the concerted action of US18 and 
US20 is a conserved function in several clinical HCMV strains36.
In conclusion, we show here that B7-H6 is not only a tumor cell marker, but might be better classified as a 
member of the stress ligand family of NK ligands, induced following cancer transformation and viral infection, as 
a method for marking cells for NK-mediated elimination.
Methods
Cells, antibodies and reagents. ARPE19 cells (ATCC CRL-2302) and HEK293T cells (ATCC CRL-
3216) were obtained from the ATCC. NK cells were cultured from blood donations of healthy adults and isolated 
and activated as previously described37. FLS1 Human foreskin fibroblasts were obtained and cultured from a 
healthy donor as previously described31. All cells originating from primary human donations were obtained in 
accordance with the institutional guidelines and permissions for using human tissues and informed consent was 
obtained from all donors. The relevant institutional committees approved all relevant experimental protocols. The 
relevant institutional Helsinki request number is 0030-12-HMO.
The following primary antibodies were used for Flow cytometry experiments: anti-B7H6 (R&D systems, clone 
875001), anti-HLA1 (W6/32), anti-beta2m (clone -02), anti-MICA (R&D systems, clone 159227), anti-MICB 
Figure 6. HCMV downregulation of B7-H6 leads to evasion from NKp30-mediated killing by NK cells. (A) 
NK cell killing of ARPE19 cells infected with different HCMV strains as depicted in the figure legend. Two 
effector to target ratios are presented as depicted on the X-axis. One representative experiment out of four is 
presented. (B) NK cell killing of ARPE19 cells infected with different HCMV strains and blocked using different 
antibodies as depicted in the figure legend. The isotype control antibody used was an anti-human CD99 
antibody. Blocking experiments were performed at a 20:1 effector to target ratio. One representative experiment 
out of four is presented. (C) NK cell killing of ARPE19 cells infected with different HCMV strains and blocked 
with either isotype control antibody (black bars, polyclonal mouse IgG1) or anti-B7-H6 antibody (grey bars). 
One representative experiment out of two is presented. For all presented experiments error bars represent 
standard error of the mean. A student’s t test was performed in order to evaluate significance. *p-value < 0.05. 
**p-value < 0.005. N.S. = non-significant differences.
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(R&D systems, clone 236511), anti-ULBP1 (R&D systems, clone 170818), anti-ULBP2 (R&D systems, clone 
165903), anti-ULBP3 (R&D systems, clone 166510), anti-PVR (in-house developed), mouse IgG1 isotype control 
(Biolegend, clone MOPC-21), mouse IgG2a isotype control (Biolegend, clone MOPC-173), and mouse IgG2b 
isotype control (Biolegend, clone MPC-11).
The following primary antibodies were used for western blot experiments: anti-FLAG (Biolegend, clone L5) 
and anti-Vinculin (Abcam EPR8185).
The following Antibodies were used for blocking of receptors or ligands during NK cytotoxicity experiments: 
anti-NKp30 (Biolegend, clone p30-15), anti-NKG2D (R&D systems, clone 149810) anti-CD99 (clone 12E7, a gift 
from A. Bernard, INSERM, France) and anti-B7-H6 (R&D systems, clone 875001).
The following secondary antibodies were used in relevant experiments: anti-mouse-AlexaFluor-647, 
anti-rat-HRP, anti-rabbit-HRP, anti-rat-AlexaFluor-647 and anti-rabbit-Cy3, all purchased from Jackson laborato-
ries. For immunofluorescence microscopy experiments the following primary antibodies were used: rat anti-FLAG 
(BioLegend, clone L5), rabbit anti-CD107A (AB2971, Merck Millipore), rabbit anti-PDI (Ab3672, Abcam).
For proteasome inhibition the following reagents were used: Epoxomycin (A2606, Apexbio) and Bortezomib 
(BNB-1408, LC Biolabs). For lysosomal inhibition Concanamycin A (27689, Sigma) and Leupeptin (Merck 
Millipore, 108976) were used.
Gene cloning and overexpression in cells. Lentiviral vectors containing different genes for overexpres-
sion were constructed using the TransIt-LT1 transfection reagent (Mirus 2306) and a transient three-plasmid 
protocol as previously described38. In brief, the human gene B7-H6 and the HCMV genes US17, US18, US19 and 
US20 were amplified from cDNA prepared from RNA of ARPE19 cells infected with HCMV TB40/e as described 
in the quantitative real-time PCR protocol in the methods section. The genes were amplified using primers con-
taining the relevant tags as detailed in Sup. Table S1. The amplified genes were inserted into one of two plas-
mid vectors - pHAGE-DsRED(−)-eGFP(+) or SIN18-pRLL-hEFIap-E-GFP-WRPE, that were used to prepare 
lentiviruses in HEK293T cells. The lentiviruses were used to transduce cells and overexpress relevant proteins. 
Transduction efficiency was validated using the FACS protocol described in the methods section.
Viruses and infection. HCMV ΔUS14-22 used in this paper is HCMV TB40/e-GFP ΔUS14-22, in which 
IRS1 and UL1 to UL6 are missing due to the insertion of the BAC vector, containing a GFP reporter under the 
CMV promoter, and deleted for US14-22 (deletion positions 211,755-220,056). The virus was prepared as previ-
ously described39.
HCMV TB40/e_GFP deletion mutants were generated by BAC recombineering in E. coli GS178340, 41 on 
the same TB40/e-GFP BAC background as the TB40/e-GFPΔUS14-22. For the TB40/e-GFPΔUS14-16, 
TB40/e-GFPΔUS16-18, TB40/e-GFPΔUS17-20 and TB40/e-GFPΔUS19-22 mutants the indicated gene regions 
were deleted by replacing them with a kanamycin cassette. The kanamycin cassette was amplified by primers each 
containing 50 bp homology to the TB40/e-GFP BAC sequence. Homology regions of primers were flanking the 
gene regions of interest. The resulting recombination fragment was electroporated into E. coli GS1783 using Bio 
Rad 0.2-cm electrode gap cuvettes and a Bio Rad Gene Pulser (2.5 kV, 25 mF, 200 V). Bacteria were plated on chlo-
ramphenicol (25 µg/ml)/kanamycin (20 µg/ml) selection plates. After 24 hours colonies were picked and checked 
for kanamycin cassette integration by colony PCR. The correct knock-in of the kanamycin cassette was verified by 
Sanger sequencing. TB40/e-GFP-US17stop, TB40/e-GFP-US18stop, TB40/e-GFP-US19stop and TB40/e-US20stop 
mutants were generated by replacing the first start codon (ATG) of each gene of interest with a stop codon (TAA). 
First, a rpsL-kana cassette was amplified and electroporated into E. coli GS1783 as described above. Homology 
regions of the primers were flanking the start codon of the genes of interest. Bacteria were selected on kanamycin 
(20 µg/ml) selection plates and insertion of the cassette was checked by colony PCR. For a second recombineering 
step the recombination fragment was generated by complementing 80 bp sense and antisense primers. Within these 
primers the 3 bp stop codon was flanked by 30–40 bp regions homologous to the TB40/e-GFP BAC sequence in 
the region where the rpsL-kana cassette is then replaced by the stop codon TAA. After electroporation bacteria 
was plated on streptomycin (5 mg/ml)/kanamycin (20 µg/ml) selection plates. Clones resistant to streptomycin were 
picked and checked for rpsL-kana cassette removal by colony PCR. The correct replacement of the start codon to the 
stop codon was verified by Sanger sequencing. The virus was prepared as previously described42. Primers used for 
the generation of the viruses are described in supplemental Tables S2 and S3.
HCMV TRUS20HA and TRΔUS20 were generated and produced as previously described33.
Briefly, HFF cells were used to propagate viral stocks. Stocks were purified and concentrated using 
ultra-centrifugation. Viral stocks were tittered on HFF cells using the plaque assay method and aliquots of viral 
stocks were preserved in −80 °C until the day of infection. Infections were performed as previously described31. 
All infections for FACS and confocal microscopy experiments were performed with MOIs of 0.1–1, and for FACS 
presented results are from the infected-cells gate only. All other experiments were performed with MOI ≥ 1.
Flow cytometry. Cells were split and grown in equal densities for at least 24 hours prior to resuspension or 
infection. Resuspended cells were counted and equal numbers of cells were stained for 1 hour on ice using pri-
mary antibodies (0.25ug/well) diluted in FACS medium (1x PBS, 0.05% Bovine Serum Albumin, 0.05% NaN3). 
Afterwards cells were washed with FACS medium and when needed stained for 30 minutes on ice with secondary 
antibodies (0.75 ug/well) diluted in FACS medium. Stained cells were read using a FACSCalibur machine (BD 
Bioscience). In all experiments in which an infection with a GFP+ virus is described, the results are of gated GFP+ 
cells.
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Quantitative real-time PCR. Cells were split and grown in equal densities for at least 24 hours prior to 
lysis. Cells were lysed and RNA was isolated using the Quick RNA Miniprep kit (Zymo). cDNA was prepared 
from 0.25–1 μg total RNA using mMLV reverse-transcriptase (Invitrogen) and oligoDT primers. The cDNA 
was mixed with 3 μM of each of the primers (forward and reverse) and 5 μl of Platinum SYBR Green qPCR 
SuperMix-UDG w/ROX (Invitrogen) was added. B7-H6 was compared between samples, HCMV US9 was meas-
ured as a control for infection levels, and hUBC together with hHPRT were used as endogenous reference genes. 
The quantitative real-time PCR reaction took place on a QuantStudio12K Flex Real Time PCR System (Applied 
Biosystems).
Western blotting. Cells were split and grown in equal densities for 72 hours prior to lysis. In the relevant 
experiments the cell culture growth media was replaced with a fresh media or fresh media containing 10 μM 
Epoxomycin, 500 μM Bortezomib, 50 nM Concanamycin A, 100 μM Leupeptin or 1:100 (vol./vol.) DMSO ten 
hours before lysis and harvesting. Lysis was performed in lysis buffer (0.6% SDS, 10 mM TRIS (pH 7.4), and 
1 mM PMSF together with Aprotinin (Sigma) as protease inhibitors) and lysates were frozen in −80 °C for at least 
24 hours. Lysates were mixed with loading dye containing 2-mercaptoethanol and separated on an acrilamide 
gel. Next, proteins were transferred to a nitrocellulose membrane, the membrane was blocked for one hour in 
room temperature (1x PBS, 5% skim milk, 0.4% Tween) and stained using the primary and secondary antibodies 
described earlier. Membranes were developed using the EZ-ECL kit (Biological Industries) and analyzed using 
the Image Lab software (Bio-Rad).
Immunofluorescent staining and confocal microscopy. Cells were plated and grown on 8-chamber 
glass slides, fixed and permeabilized for 10 minutes by −20 °C methanol, and blocked overnight in 4 °C using 
CAS-block (Thermo Fisher Scientific) supplemented with human serum. The following day the cells were stained 
with the relevant primary antibodies diluted in CAS-block overnight in 4 °C. Afterwards the slides were washed 
and incubated with fluorescently-labeled secondary antibodies for 2 hours in room temperature. The cells were 
washed again, stained with 4′,6-diamidino-2-phenylindole (DAPI) for 4.5 minutes in room temperature, and 
visualized using an Olympus Fluoview FV1000 confocal microscope. Image quantification was performed using 
the Olympus Fluoview FV1000 software.
NK cell cytotoxicity assays. Natural killer cells cytotoxicity experiments were performed as previously 
described31.
Statistical methods. A Student’s t-test or an ANOVA test were performed in order to check for significance 
as stated in the text. Significance was considered when p < 0.05 or lower, as stated in the text. For correlation 
measurement Pearson’s coefficient was calculated.
All experiments and experimental protocols described in this paper were performed in accordance with the 
Hebrew University safety and ethics guidelines and regulations.
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